Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.

J Clin Oncol · 2019 · PMC6544462 · PMID 30875280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In CS III patients, there is also a highly significant decrease in miR levels after the first cycle of chemotherapy, with the second cycle producing further significant decreases.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.